Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 01, 2022	Sep. 24, 2021
Current assets:
Cash and cash equivalents	$ 858,905	$ 1,225,380
Restricted cash	8,352	7,652
Short-term investments	156,812	38,839
Accounts receivable, net of allowance for credit losses of $9,572 and $8,744	236,229	232,609
Contract assets, net of allowance for credit losses of $123 and $208	170,402	182,316
Inventories, net	24,096	10,965
Prepaid expenses and other current assets	49,923	62,737
Total current assets	1,504,719	1,760,498
Long-term investments	106,726	62,819
Property, plant and equipment, net	517,870	534,381
Operating lease right-of-use assets	53,702	67,128
Intangible assets, net	119,251	122,890
Goodwill	368,282	340,694
Other non-current assets	65,841	61,257
Deferred taxes	183,545	156,020
Total assets	2,919,936	3,105,687
Current liabilities:
Accounts payable	16,821	17,779
Accrued liabilities	229,267	262,728
Income taxes payable	3,850	1,334
Contract liabilities	21,216	18,473
Operating lease liabilities	14,331	15,403
Total current liabilities	285,485	315,717
Non-current contract liabilities	24,350	23,713
Non-current operating lease liabilities	44,257	56,715
Other non-current liabilities	106,319	105,310
Total liabilities	460,411	501,455
Stockholders’ equity:
Retained earnings	2,484,689	2,607,909
Accumulated other comprehensive loss	(30,426)	(10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,454,361	2,597,979
Controlling interest	5,164	6,253
Total stockholders’ equity	2,459,525	2,604,232
Total liabilities and stockholders’ equity	2,919,936	3,105,687
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 62,578,760 shares issued and outstanding at July 1, 2022 and 64,986,316 at September 24, 2021
Stockholders’ equity:
Common stock	57	59
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,629 shares issued and outstanding at July 1, 2022 and 36,086,779 at September 24, 2021
Stockholders’ equity:
Common stock	$ 41	$ 41